ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.439,78
0,83%
S&P 500
5.464,62
-0,16%
US Dollar vs BRL
5,4434
-0,19%
Bitcoin
64.355,81
-0,72%
Brent Oil
84,43
-0,68%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Boundless Bio Inc (BOLD)

  7. Boundless Bio Inc (BOLD) Notícias

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BOLD
DataHoraFonteTítuloCódigoCompanhia
05/06/202408:00Business WireBoundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
13/05/202408:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BOLDBoundless Bio Inc
13/05/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
13/05/202408:00Business WireBoundless Bio Reports First Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:BOLDBoundless Bio Inc
06/05/202409:00Business WireBoundless Bio to Present at the Citizens JMP Life Sciences Conference 2024NASDAQ:BOLDBoundless Bio Inc
11/04/202409:00Business WireBoundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene AmplificationsNASDAQ:BOLDBoundless Bio Inc
08/04/202409:00Business WireBoundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024NASDAQ:BOLDBoundless Bio Inc
14/02/202019:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
11/02/202018:41Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BOLDBoundless Bio Inc
27/01/202011:38Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:BOLDBoundless Bio Inc
21/01/202008:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BOLDBoundless Bio Inc
03/12/201921:13PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Audentes Therapeutics, Inc.NASDAQ:BOLDBoundless Bio Inc
02/12/201920:01Business WireAstellas Enters into Definitive Agreement to Acquire Audentes TherapeuticsNASDAQ:BOLDBoundless Bio Inc
26/11/201918:01Business WireAudentes Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BOLDBoundless Bio Inc
12/11/201919:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
07/11/201919:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BOLDBoundless Bio Inc
07/11/201918:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
07/11/201918:01Business WireAudentes Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:BOLDBoundless Bio Inc
31/10/201908:00Business WireAudentes Therapeutics to Release Third Quarter 2019 Financial Results and Provide Corporate Update on Thursday, November 7, 2...NASDAQ:BOLDBoundless Bio Inc
05/10/201908:01Business WireAudentes Therapeutics Presents New Positive Data from ASPIRO, the Clinical Trial Evaluating AT132 in Patients with X-Linked M...NASDAQ:BOLDBoundless Bio Inc
04/10/201919:00Business WireAudentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BOLDBoundless Bio Inc
30/09/201909:00Business WireAudentes Announces Upcoming Presentations at the 24th International Annual Congress of the World Muscle Society, Including Ne...NASDAQ:BOLDBoundless Bio Inc
23/08/201917:03Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:BOLDBoundless Bio Inc
06/08/201917:01PR Newswire (US)Audentes Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:BOLDBoundless Bio Inc
30/07/201909:00PR Newswire (US)Audentes Therapeutics to Release Second Quarter 2019 Financial Results and Provide Corporate Update on Tuesday, August 6, 201...NASDAQ:BOLDBoundless Bio Inc
17/07/201917:25Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BOLDBoundless Bio Inc
29/05/201917:01PR Newswire (US)Audentes Therapeutics Announces Changes to Senior Management TeamNASDAQ:BOLDBoundless Bio Inc
13/05/201907:04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BOLDBoundless Bio Inc
08/05/201909:00PR Newswire (US)Audentes Therapeutics to Participate in the Bank of America Merrill Lynch 2019 Health Care ConferenceNASDAQ:BOLDBoundless Bio Inc
07/05/201917:01PR Newswire (US)Audentes Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:BOLDBoundless Bio Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:BOLD

Seu Histórico Recente

LSE
TP15
Citi Fun 24
USOTC
ERYTF
Eagle Royalties (CE)
COIN
NAOETH
NFTDAO
USOTC
LBYE
Liberty Energy (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados